Burning Rock Biotech LTD (BNR) — SEC Filings

Q: What are the key financial highlights for Burning Rock Biotech LTD?

Key financial highlights for Burning Rock Biotech LTD are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Burning Rock Biotech LTD?

Key executives at Burning Rock Biotech LTD are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Burning Rock Biotech LTD stock?

Risk factors for Burning Rock Biotech LTD (BNR) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Burning Rock Biotech LTD?

Forward-looking statements and predictions from Burning Rock Biotech LTD are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Burning Rock Biotech LTD. Recent 6-K filing on Dec 23, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Burning Rock Biotech LTD on SEC EDGAR

Overview

Burning Rock Biotech LTD (BNR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 1, 2025: Burning Rock Biotech Limited filed a Form 6-K on December 1, 2025, for the month of December 2025. The filing includes a press release, notice of the Annual General Meeting, and proxy materials for ADS holders. The company is registered in the People's Republic of China and its principal executive o

Sentiment Summary

Across 29 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 27 neutral. The dominant filing sentiment for Burning Rock Biotech LTD is neutral.

Filing Type Overview

Burning Rock Biotech LTD (BNR) has filed 20 6-K, 2 20-F, 1 20-F/A, 4 SC 13G/A, 2 SC 13G with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (29)

6-K Filing — 6-K · Dec 23, 2025
Burning Rock Biotech Files December 2025 6-K — 6-K · Dec 1, 2025 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on December 1, 2025, for the month of December 2025. The filing includes a press release, notice of the Annual Gen
6-K Filing — 6-K · Nov 20, 2025
Burning Rock Biotech Files 6-K Report — 6-K · Sep 8, 2025 Risk: low
Burning Rock Biotech Ltd. filed a Form 6-K on September 8, 2025, reporting for the month of September 2025. The filing is from their principal executive offices
Burning Rock Biotech Files 6-K — 6-K · Jun 6, 2025 Risk: low
Burning Rock Biotech Ltd. filed a Form 6-K on June 6, 2025, for the month of June 2025. The filing incorporates by reference Exhibit 99.1, excluding specific no
Burning Rock Biotech Files 2024 Annual 20-F Report — 20-F · Apr 29, 2025 Risk: medium
Burning Rock Biotech Ltd filed its annual 20-F report for the fiscal year ending December 31, 2024. The filing, submitted on April 29, 2025, provides comprehens
Burning Rock Biotech Files 6-K for March 2025 — 6-K · Mar 25, 2025 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on March 25, 2025, to incorporate by reference certain information from Exhibit 99.1. This filing is for the month
Burning Rock Biotech Files 6-K for December 2024 — 6-K · Dec 31, 2024 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on December 31, 2024, for the month of December 2024. The filing includes a press release as Exhibit 99.1. The com
Burning Rock Biotech Files 6-K Report — 6-K · Dec 4, 2024 Risk: low
Burning Rock Biotech Ltd. filed a Form 6-K on December 4, 2024, incorporating by reference certain information from Exhibit 99.1. This filing is for the month o
Burning Rock Biotech Files 6-K with AGM Notices — 6-K · Dec 3, 2024 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on December 3, 2024, for the month of December 2024. The filing includes a press release, notice of the Annual Gen
Burning Rock Biotech Files 20-F Amendment — 20-F/A · Nov 26, 2024 Risk: medium
Burning Rock Biotech Ltd filed an amendment (Amendment No. 1) to its 20-F form for the fiscal year ending December 31, 2023. This filing, dated November 26, 202
SC 13G/A Filing — SC 13G/A · Nov 14, 2024
Burning Rock Biotech Files 6-K Report — 6-K · Sep 27, 2024 Risk: low
Burning Rock Biotech Ltd. filed a Form 6-K on September 27, 2024. This report is for the month of September 2024 and is filed by a foreign private issuer. The c
Burning Rock Biotech Files 6-K, Incorporates into F-3/S-8 — 6-K · Sep 20, 2024 Risk: low
Burning Rock Biotech Ltd. filed a Form 6-K on September 20, 2024, to report information for the month of September 2024. The filing is incorporated by reference
Burning Rock Biotech Files 6-K Report — 6-K · Sep 6, 2024 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on September 6, 2024. This report is for the month of September 2024 and is filed by a foreign private issuer. The
Burning Rock Biotech Files 6-K Report — 6-K · Aug 23, 2024 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on August 23, 2024, incorporating by reference Exhibit 99.1. This filing is for the month of August 2024 and perta
Burning Rock Biotech Files August 6-K Report — 6-K · Aug 19, 2024 Risk: low
Burning Rock Biotech Ltd. filed a Form 6-K on August 19, 2024, to report its activities for the month of August 2024. The filing includes a press release as Exh
Burning Rock Biotech Files 6-K Report — 6-K · Jun 3, 2024 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on June 3, 2024, incorporating by reference certain information from Exhibit 99.1. The filing pertains to the mont
Burning Rock Biotech Files 6-K Report — 6-K · May 29, 2024 Risk: low
Burning Rock Biotech Ltd. filed a Form 6-K on May 29, 2024, incorporating by reference certain information from Exhibit 99.1. This filing pertains to the month
Burning Rock Biotech Files 6-K, Incorporates Press Release — 6-K · May 14, 2024 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on May 14, 2024, incorporating by reference a press release as Exhibit 99.1. This filing relates to their registra
Burning Rock Biotech Ltd Files 20-F Annual Report — 20-F · Apr 29, 2024 Risk: medium
Burning Rock Biotech Ltd (BNR) filed a Foreign Annual Report (20-F) with the SEC on April 29, 2024. Filing is the annual 20-F report for Burning Rock Biotech Lt
Burning Rock Biotech Files 6-K, Incorporates Press Release — 6-K · Apr 26, 2024 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on April 26, 2024, incorporating by reference a press release as Exhibit 99.1. This filing relates to their regist
Burning Rock Biotech Files 6-K for March 2024 — 6-K · Mar 28, 2024 Risk: low
Burning Rock Biotech Limited filed a Form 6-K on March 28, 2024, incorporating by reference certain information from Exhibit 99.1. This filing is for the month
SC 13G/A Filing — SC 13G/A · Feb 14, 2024
SC 13G/A Filing — SC 13G/A · Feb 14, 2024
SC 13G Filing — SC 13G · Feb 13, 2024
GIC Private Ltd Updates Burning Rock Biotech Stake as of Dec 31, 2023 — SC 13G/A · Feb 9, 2024 Risk: low
GIC Private Ltd, a Singaporean sovereign wealth fund, has filed an amendment to its SC 13G filing for Burning Rock Biotech Ltd, indicating its ownership stake a
Kynam Capital Discloses 8.7M Share Stake in Burning Rock Biotech — SC 13G · Jan 10, 2024
Kynam Capital Management, LP, a Delaware-based investment firm, reported owning 8,694,426 Class A Ordinary Shares of Burning Rock Biotech Ltd (BRCK) as of Decem
Burning Rock Biotech Receives Nasdaq Minimum Bid Price Non-Compliance Notice — 6-K · Jan 4, 2024
Burning Rock Biotech Ltd. (NASDAQ: BNR) received a notification from Nasdaq on December 29, 2023, stating that its American depositary shares (ADSs) traded belo

Risk Profile

Risk Assessment: Of BNR's 21 recent filings, 0 were flagged as high-risk, 3 as medium-risk, and 18 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

Yusheng Han
Leo Li

Top Tags

reporting (10) · foreign-private-issuer (7) · sec-filing (5) · press-release (4) · filing (3) · 6-K (3) · 6-k (3) · foreign-issuer (3) · agm (2) · 20-F (2)

Key Numbers

Fiscal Year End: 2024-12-31 — The period covered by the 20-F report.
Filing Date: 2025-04-29 — The date the 20-F was officially submitted to the SEC.
Reporting Period End Date: 20241231 — Indicates the period covered by the filing.
Commission File Number: 001-39316 — Identifies the specific SEC filing
SEC File Number: 001-39316 — SEC file number for Burning Rock Biotech Ltd
Film Number: 24886421 — Film number associated with the filing
Amendment Number: 2 — This is the second amendment to the original SC 13G filing by GIC Private Ltd.
CUSIP Number: 12233L107 — Identifies the American depositary shares of Burning Rock Biotech Ltd.
Filed As Of Date: 20240209 — The date the SC 13G/A was filed with the SEC.
Par Value: US$0.0002 — The par value per Class A ordinary share of Burning Rock Biotech Ltd.

Forward-Looking Statements

{"claim":"GIC Private Ltd will maintain its stake in Burning Rock Biotech Ltd for the foreseeable future.","entity":"GIC Private Ltd","targetDate":"December 31, 2024","confidence":"medium"}
{"claim":"Burning Rock Biotech Ltd's stock price will experience minor positive sentiment due to continued institutional holding.","entity":"Burning Rock Biotech Ltd","targetDate":"March 31, 2024","confidence":"low"}

Frequently Asked Questions

What are the latest SEC filings for Burning Rock Biotech LTD (BNR)?

Burning Rock Biotech LTD has 29 recent SEC filings from Jan 2024 to Dec 2025, including 20 6-K, 4 SC 13G/A, 2 20-F. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of BNR filings?

Across 29 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 27 neutral. The dominant sentiment is neutral.

Where can I find Burning Rock Biotech LTD SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Burning Rock Biotech LTD (BNR) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Burning Rock Biotech LTD?

Financial highlights for Burning Rock Biotech LTD are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for BNR?

The investment thesis for BNR includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Burning Rock Biotech LTD?

Key executives identified across Burning Rock Biotech LTD's filings include Yusheng Han, Leo Li.

What are the main risk factors for Burning Rock Biotech LTD stock?

Of BNR's 21 assessed filings, 0 were flagged high-risk, 3 medium-risk, and 18 low-risk.

What are recent predictions and forward guidance from Burning Rock Biotech LTD?

Recent forward-looking statements from Burning Rock Biotech LTD include guidance on {"claim":"GIC Private Ltd will maintain its stake in Burning Rock Biotech Ltd for the foreseeable future.","entity":"GIC and 1 other predictions.